Integrating scRNA-seq and machine learning identifies MNAT1 as a therapeutic target in OSCC
Frontiers in Immunology · 2025
DOI: 10.3389/fimmu.2025.1663487 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Immunology, 2025. Verfasst von Han Gao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Stomatology, First Affiliated Hospital of Huzhou University, The First People's Hospital of Huzhou, Huzhou, Zhejiang, China. Hauptthemen laut MEDLINE: Mouth Neoplasms, Machine Learning, Tumor Suppressor Proteins, Biomarkers, Tumor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Oral squamous cell carcinoma, with high global incidence and mortality, requires improved early intervention strategies. Ubiquitination - a critical post-translational modification - has been strongly implicated in tumorigenesis, with particularly significant roles in T-cell regulation. We developed a T Cell-Related ubiquitination risk model that enhances prognostic prediction and immunotherapy response assessment, offering a framework for personalized OSCC manageme.
Method
T cell-Related Ubiquitination genes were identified based on scRNA-seq analysis, and key genes were selected using WGCNA and LASSO algorithms to construct a prognostic model. Spearman correlation analysis revealed significant associations between riskScore and immune infiltration levels, checkpoint molecule expression, and MMR activity. Pseudotemporal trajectory and cell-cell communication analyses delineated dynamic gene expression patterns driving OSCC progression. Functional validation through colony formation and Transwell assays confirmed the tumor-suppressive effects of key model genes.
Results
Given the high correlation between T cell-Related Ubiquitination genes and the prognosis of OSCC patients, a prognostic model based on patient scRNA-seq data was constructed and validated. The RiskScore derived from our model correlated significantly with expression levels of MMR genes, abundance of immune checkpoint proteins, and immunotherapy response. Cell-cell communication analysis further elucidated epithelial-macrophage crosstalk via MIF and IFN-II signaling, suggesting microenvironment-driven progression mechanisms. In vitro functional assays showed that depletion of MNAT1 impaired Cal27 cell proliferation and migration capacity.
Conclusions
Collectively, integrating T cell-Related Ubiquitination genes through advanced computational analyses, we established a robust prognostic model for OSCC and identified MNAT1 as a promoter of malignant progression, highlighting its therapeutic potential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Stomatology, First Affiliated Hospital of Huzhou University, The First People's Hospital of Huzhou, Huzhou, Zhejiang, China.
Zitieren
APA
Gao, H., Liu, L., Qian, W., Wu, Y., Wang, J., Yang, W., & Shi, Y. (2025). Integrating scRNA-seq and machine learning identifies MNAT1 as a therapeutic target in OSCC. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2025.1663487
Vancouver
Gao H, Liu L, Qian W, Wu Y, Wang J, Yang W, et al. Integrating scRNA-seq and machine learning identifies MNAT1 as a therapeutic target in OSCC. Frontiers in Immunology. 2025. doi:10.3389/fimmu.2025.1663487
BibTeX
@article{Gao2025,
author = {Gao, Han and Liu, Lehua and Qian, Weixiang and Wu, Yanfei and Wang, Jiayao and Yang, Weiping and Shi, Yinfang},
title = {Integrating scRNA-seq and machine learning identifies MNAT1 as a therapeutic target in OSCC},
journal = {Frontiers in Immunology},
year = {2025},
doi = {10.3389/fimmu.2025.1663487}
}
EUVIMED